Transactions

Deal Showcase

About Transactions

Latigo Biotherapeutics Initial Public Offering

Published: August 2026
Biopharma DNA strand composition

More Transactions

$125 Million
Joint Bookrunner
Follow-On
February 2023
$119 Million
Joint Bookrunner
Follow-On
October 2021
$150 Million
Joint Bookrunner
Follow-On
December 2023
$35 Million
Exclusive Financial Advisor
Series C Financing Led by MultiPlan Corporation
June 2022
View all Transactions

Featured Insights

VIEW ADDITIONAL INSIGHTS
Banner desktop

Partner with us

To achieve your strategic, capital markets, and investment objectives.

Contact Us

Our experienced team is happy to assist you. Please complete the form below and we’ll be in touch as soon as possible. “*” indicates required fields

This field is for validation purposes and should be left unchanged.
Consent(Required)